Cargando…
Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IJS Publishing Group Ltd. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533875/ https://www.ncbi.nlm.nih.gov/pubmed/35995352 http://dx.doi.org/10.1016/j.ijsu.2022.106847 |
_version_ | 1784802432801308672 |
---|---|
author | Chakraborty, Sandip Chandran, Deepak Mohapatra, Ranjan K. Alagawany, Mahmoud El-Shall, Nahed A. Sharma, Anil K. Chakraborty, Chiranjib Dhama, Kuldeep |
author_facet | Chakraborty, Sandip Chandran, Deepak Mohapatra, Ranjan K. Alagawany, Mahmoud El-Shall, Nahed A. Sharma, Anil K. Chakraborty, Chiranjib Dhama, Kuldeep |
author_sort | Chakraborty, Sandip |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9533875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | IJS Publishing Group Ltd. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95338752022-10-07 Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects Chakraborty, Sandip Chandran, Deepak Mohapatra, Ranjan K. Alagawany, Mahmoud El-Shall, Nahed A. Sharma, Anil K. Chakraborty, Chiranjib Dhama, Kuldeep Int J Surg Correspondence IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022-09 2022-08-19 /pmc/articles/PMC9533875/ /pubmed/35995352 http://dx.doi.org/10.1016/j.ijsu.2022.106847 Text en © 2022 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved. Elsevier has created a Monkeypox Information Center in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active. |
spellingShingle | Correspondence Chakraborty, Sandip Chandran, Deepak Mohapatra, Ranjan K. Alagawany, Mahmoud El-Shall, Nahed A. Sharma, Anil K. Chakraborty, Chiranjib Dhama, Kuldeep Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects |
title | Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects |
title_full | Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects |
title_fullStr | Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects |
title_full_unstemmed | Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects |
title_short | Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects |
title_sort | clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. an update on current knowledge and futuristic prospects |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533875/ https://www.ncbi.nlm.nih.gov/pubmed/35995352 http://dx.doi.org/10.1016/j.ijsu.2022.106847 |
work_keys_str_mv | AT chakrabortysandip clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT chandrandeepak clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT mohapatraranjank clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT alagawanymahmoud clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT elshallnaheda clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT sharmaanilk clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT chakrabortychiranjib clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects AT dhamakuldeep clinicalmanagementantiviraldrugsandimmunotherapeuticsfortreatingmonkeypoxanupdateoncurrentknowledgeandfuturisticprospects |